default author photo

Erhard Seifried

German Red Cross Blood Transfusion Service

SCHOLARLY PAPERS

1

DOWNLOADS

164

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial

Number of pages: 37 Posted: 09 Nov 2024
University of Ulm, Charité - Universitätsmedizin Berlin, University of Besançon - Université de Franche-Comté, Charité - Universitätsmedizin Berlin, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University of Ulm, Stauferklinikum Schwäbisch Gmünd, University of Ulm, University of Ulm, Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, University of Ulm, University of Ulm, University of Ulm, University of Ulm, University of Ulm, University of Ulm, Charité - Universitätsmedizin Berlin - Department of Nephrology and Medical Intensive Care, German Red Cross Blood Transfusion Service, University of Ulm, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University of Besançon - Université de Franche-Comté, University Hospital Ulm, Besançon Clinical Investigation Center, University of Besançon - Université de Franche-Comté, German Red Cross Blood Transfusion Service, UK Health Security Agency, University of Oxford, University of Oxford, University of Besançon - Université de Franche-Comté, Erasmus MC, University Medical Center, Aix-Marseille University - Etablissement Français du Sang (EFS) and Ulm University - Ulm University Hospital
Downloads 164 (456,852)
Citation 1

Abstract:

Loading...

convalescent plasma, COVID-19, randomized trial, neutralizing antibody, SARS-CoV-2